Connection

Anders Sönnerborg to Reverse Transcriptase Inhibitors

Back to Details
This is a "connection" page, showing publications Anders Sönnerborg has written about Reverse Transcriptase Inhibitors.
Anders Sönnerborg
Connection Strength
0.486
Reverse Transcriptase Inhibitors
  1. A viral genome wide association study and genotypic resistance testing in patients failing first line antiretroviral therapy in the first large countrywide Ethiopian HIV cohort. BMC Infect Dis. 2019 Jul 01; 19(1):569.
    View in: PubMed
    Score: 0.170
  2. Antiretroviral potency of 4'-ethnyl-2'-fluoro-2'-deoxyadenosine, tenofovir alafenamide and second-generation NNRTIs across diverse HIV-1 subtypes. J Antimicrob Chemother. 2018 10 01; 73(10):2721-2728.
    View in: PubMed
    Score: 0.162
  3. Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations. Int J Antimicrob Agents. 2018 May; 51(5):733-738.
    View in: PubMed
    Score: 0.154
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.